Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on May 13, 2025
Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia
GlobeNewswire
·
May 13, 2025
SARASOTA, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that it has received approval from the Human …
ZenaTech Expands Drone-as-a-Service (DaaS) Exterior Building Power Washing to Dubai Tapping into a Global Drone Cleaning Services Market Growing to USD 13 Billion by 2030
GlobeNewswire
·
May 13, 2025
VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS, and …
VERB Beats All Analysts Q1 2025 Financial Performance Estimates
GlobeNewswire
·
May 13, 2025
Management Delivers Impressive 80% Revenue Growth Quarter-Over-Quarter Beats All Revenue and EPS Estimates By A Wide Margin Q1 2025 Revenue Exceeds Entire 2024 Annual Revenue Closed $8.5 Million Acquisition Of AI Social Commerce Technology Platform Lyvecom …
Wearable Devices Receives U.S. Patent Notice of Allowance for Hybrid Voice and Gesture Control Innovation
GlobeNewswire
·
May 13, 2025
Newly allowed patent extends Wearable Devices’ innovative gesture technology into the domain of voice control YOKNEAM ILLIT, ISRAEL, May 13, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a …
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101
GlobeNewswire
·
May 13, 2025
- BMB-101 demonstrated a complete elimination of drop attacks in the DBA/2 mouse model - - The DBA/2 model is highly predictive of sudden unexpected death in epilepsy (SUDEP) - - Findings highlight BMB-101’s potential to address critical gaps in SUDEP …
Atsign's NoPorts Solution Creates First "Invisible Cloud" on Amazon Web Services (AWS)
GlobeNewswire
·
May 13, 2025
SAN JOSE, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Atsign today announced the successful deployment of an "invisible cloud" environment on Amazon Web Services (AWS), leveraging its innovative NoPorts technology. This breakthrough delivers a new level of …
Cycurion Secures $33 Million Contract Renewal to Enhance Cybersecurity for State-Level Public Higher Education Institutions
GlobeNewswire
·
May 13, 2025
MCLEAN, Va., May 13, 2025 (GLOBE NEWSWIRE) -- Cycurion (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, announces that it has been awarded a significant contract renewal by a major state-level public …
Affimed Announces Filing for the Opening of Insolvency Proceedings
GlobeNewswire
·
May 13, 2025
MANNHEIM, Germany, May 13, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced its decision to file an application for …
XRP News: Vaultro Finance Presale Moves Fast — Early Investors Eye Massive 30% Listing Gain on XRP’s Hottest DeFi Protocol
GlobeNewswire
·
May 13, 2025
SINGAPORE, May 13, 2025 (GLOBE NEWSWIRE) -- With XRP breaking past $2.50 and reclaiming its position as one of the top three cryptocurrencies by market cap, investor enthusiasm is flooding into the XRP Ledger ecosystem, and one project is stealing the …
Delinea Begins FedRAMP High Authorization Process for Secret Server
GlobeNewswire
·
May 13, 2025
SAN FRANCISCO, May 13, 2025 (GLOBE NEWSWIRE) -- Delinea, a pioneering provider of solutions for securing human and machine identities through centralized authorization, has initiated the FedRAMP High authorization process for Secret Server, an industry- …
Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
May 13, 2025
Announced accepted oral presentation of positive phase 3 randomized placebo controlled clinical trial results of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting …
Plotly Honored as Bronze Stevie Award Winner In 2025 American Business Awards
GlobeNewswire
·
May 13, 2025
MONTREAL, May 13, 2025 (GLOBE NEWSWIRE) -- Plotly, the premier Data App platform for Python, has been named a Bronze Stevie® Award winner in the Artificial Intelligence/ Machine Learning Solution – Other category in The 23rd Annual American Business Awards …
SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury
GlobeNewswire
·
May 13, 2025
DENVER, May 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced …
Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
GlobeNewswire
·
May 13, 2025
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …
Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference
GlobeNewswire
·
May 13, 2025
CARLSBAD, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a …
Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 13, 2025
SOLANA BEACH, Caif., May 13, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, …
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
GlobeNewswire
·
May 13, 2025
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will …
Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway
GlobeNewswire
·
May 13, 2025
IND cleared for pan-RAS molecular glue ERAS-0015 and IND submitted for pan-KRAS inhibitor ERAS-4001, both ahead of schedule; Phase 1 monotherapy data for both programs expected in 2026 Meaningful extension of cash runway guidance from H2 2027 to H2 2028 …
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 13, 2025
Continued Progress in Ongoing Late-Stage Netherton Syndrome Studies Announced Positive Clinical Data for Adult and Pediatric Netherton Patients Provided Clear Visual Evidence of QRX003 Mechanism of Action Patent Portfolio Expanded to Support Pipeline …
Microchip Opens Registration for its 25th Annual MASTERs Conference in Scottsdale, Arizona
GlobeNewswire
·
May 13, 2025
CHANDLER, Ariz., May 13, 2025 (GLOBE NEWSWIRE) -- Microchip Technology (Nasdaq: MCHP) today announces that registration is now open for its MASTERs Conference in North America, the premier technical training event for embedded design engineers. This year …